✦ LIBER ✦

PMS21 COST-EFFECTIVENESS SIMULATION MODEL OF ABATACEPT VERSUS RITUXIMAB IN RHEUMATOID ARTHRITIS IN FRANCE

✍ Scribed by L Gossec; P Goupille; A Saraux; B Bregman; E Boccard; D Dupont; A Beresniak

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS21 ABATACEPT OR INFLIXIMAB FOR RHEUMA

✍ R. Alfonso-Cristancho; N. Serra; E.C. Aiello; C.N. Roa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PMS25 COST-EFFECTIVENESS OF ABATACEPT OR

✍ R. Alfonso-Cristancho; E.C. Aiello; C.N. Roa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS11 COST-EFFECTIVENESS ANALYSIS OF RIT

✍ SF Lou; DY Chen; TT Cheng; CM Huang; HY Lin; CC Su; WC Tsai; JC Tseng; CC Wei; L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PMS21 COST—EFFECTIVENESS OF RITUXIMAB VS

✍ LA Bynum; N Joshi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PMS10 THE COST-EFFECTIVENESS OF ABATACEP

✍ Y Yuan; M Maier-Moldovan; R Maclean; GJ L'Italien 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMS71 A COST-EFFECTIVENESS ASSESSMENT OF

✍ V Brodszky; F Borgström; S Arnetorp; M Péntek; L Gulácsi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB